您当前的位置:
首页 >
文章列表页 >
Apixaban for the prevention and treatment of cancer-associated venous thromboembolism: a rapid health technology assessment
更新时间:2025-05-23
    • Apixaban for the prevention and treatment of cancer-associated venous thromboembolism: a rapid health technology assessment

    • ZHONGGUO YAOFANG   Vol. 36, Issue 10, Pages: 1260-1265(2025)
    • DOI:10.6039/j.issn.1001-0408.2025.10.19    

      CLC: R973+.2;R969.3
    • Received:20 November 2024

      Revised:07 April 2025

      Accepted:07 April 2025

      Published:30 May 2025

    移动端阅览

  • WANG Huayu,SHANGGUAN Keke,WANG Ying,et al.Apixaban for the prevention and treatment of cancer-associated venous thromboembolism: a rapid health technology assessment[J].ZHONGGUO YAOFANG,2025,36(10):1260-1265. DOI: 10.6039/j.issn.1001-0408.2025.10.19.

  •  
  •  

0

Views

0

下载量

0

CSCD

Alert me when the article has been cited
提交
Tools
Download
Export Citation
Share
Add to favorites
Add to my album

Related Articles

Rapid health technology assessment of tirzepatide for diabetes mellitus type 2 and long-term weight management
钙离子通道调节剂治疗糖尿病周围神经病理性疼痛的快速卫生技术评估
Rapid health technology assessment of the efficacy, safety and cost-effectiveness of vericiguat in the treatment of heart failure
Semaglutide in the treatment of type 2 diabetes mellitus: rapid health technology assessment
Rapid health technology assessment of Xuesaitong injection in the treatment of stroke

Related Author

CAO Weiling
ZHENG Guimei
CAO Yaohua
LIANG Zhuoru
LIU Yinuo
XIE Zeyu
LIU Guoqiang
ZHANG Yuxi

Related Institution

School of Public Health, Southern Medical University
Dept. of Pharmacy, Shenzhen Luohu District People’s Hospital
School Hospital of Anhui Medical University
Dept. of Gastroenterology, Anqing Municipal Hospital
0